首页> 外文期刊>HPB Surgery >Clinical and Enzymatic Investigation of Induction of Oxygen Free Radicals by Ischemia and Reperfusion in Human Hepatocellular Carcinoma and Adjacent Liver
【24h】

Clinical and Enzymatic Investigation of Induction of Oxygen Free Radicals by Ischemia and Reperfusion in Human Hepatocellular Carcinoma and Adjacent Liver

机译:肝细胞癌和邻近肝组织缺血再灌注诱导氧自由基的临床和酶学研究

获取原文
       

摘要

Serum concentration of thiobarbituric acid (TBA) reactants in the hepatic vein were measured beforeand after transient dearterialization of the liver in five human subjects bearing unresectablehepatocellular carcinoma (HCC). During 1 hour of the occlusion of the hepatic artery, change inTBAreactants level was slight. However, the mean value of TBA reactants in 1 hour after the reflowincreased to 1.50 ± 0.11 nmol/ml (mean ± S.E.) and was significantly higher (p < 0.05) than thosebefore hepatic dearterialization (1.28 ± 0.11 nmol/ml) and just before the release of occlusion (1.32 ±0.09 nmol/ml).Further, two endogeneous scavenger enzymes, superoxide dismutase (SOD) and catalase (CAT),and one of the major sources of oxygen free radicals, xanthine oxidase (XOD) were measured inhuman untreated HCC and the corresponding adjacent liver tissue. The results demonstrated anincrease in SOD in 81.8% (9/11) of HCC, and a decrease in CAT in 72.7% (8/11) of HCC whencompared with the corresponding adjacent liver tissue. The mean value of SOD in HCC wassignificantly higher (66.8 ± 6.5 vs 52.8 ± 3.8 U/mg protein; p < 0.05), and that of CAT wassignificantly lower (22.6 ± 2.4 vs 36.0 ± 6.1 U/mg protein; p < 0.05) than those in liver tissue. All ofnine HCC samples had a significantly lower activity of XOD (6.4 ± 1.9 vs 20.3 ± 3.4 pmol/minute/mgprotein; p < 0.01) than the corresponding liver tissue. There was no obvious relation between thecontent of SOD and CAT in HCC, or in liver tissue.These data may suggest that oxygen free radicals can be generated in human HCC by ischemiaand reperfusion of the tumor- bearing liver. It is also indicated that the antioxidant system of HCC isnot always impaired, and that HCC might develop several lines of defence systems against theoxidative attack. A possible strategy of the treatment for liver tumor with oxygen derived free radicalsinduced by ischemia and reperfusion is hypothized here.
机译:在五个患有不可切除的肝细胞癌(HCC)的人类受试者中,对肝脏进行短暂的脱盐之前和之后,测量了肝静脉中的硫代巴比妥酸(TBA)反应物的血清浓度。在肝动脉闭塞的1小时内,TBA反应物水平变化很小。然而,回流后1小时内TBA反应物的平均值增加到1.50±0.11 nmol / ml(平均值±SE),并且显着高于(p <0.05)肝脱盐前(1.28±0.11 nmol / ml)和之前。释放的阻塞(1.32±0.09 nmol / ml)。另外,在人类中还测定了两种内源清除剂,超氧化物歧化酶(SOD)和过氧化氢酶(CAT),以及氧自由基的主要来源之一,黄嘌呤氧化酶(XOD)。未经治疗的肝癌和相应的邻近肝组织。结果表明,与相应的相邻肝组织相比,HCC中SOD升高了81.8%(9/11),而CAT中CAT降低了72.7%(8/11)。 HCC中SOD的平均值显着较高(66.8±6.5 vs 52.8±3.8 U / mg蛋白; p <0.05),而CAT的平均值显着较低(22.6±2.4 vs 36.0±6.1 U / mg蛋白; p <0.05)比肝组织中的那些所有的HCC样本的XOD活性均显着低于相应的肝组织(6.4±1.9 vs 20.3±3.4 pmol /分钟/ mg蛋白; p <0.01)。在肝癌或肝组织中,SOD和CAT的含量之间没有明显的关系。这些数据可能表明,人肝癌中荷瘤肝的缺血和再灌注可产生氧自由基。还表明,HCC的抗氧化系统并不总是受损的,并且HCC可能会发展出针对氧化攻击的防御系统。本文假设了一种由缺血和再灌注引起的氧衍生自由基治疗肝肿瘤的可能策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号